These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21474491)

  • 61. Virtual screen for ligands of orphan G protein-coupled receptors.
    Bock JR; Gough DA
    J Chem Inf Model; 2005; 45(5):1402-14. PubMed ID: 16180917
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Insight into the binding mode for cyclopentapeptide antagonists of the CXCR4 receptor.
    Våbenø J; Nikiforovich GV; Marshall GR
    Chem Biol Drug Des; 2006 May; 67(5):346-54. PubMed ID: 16784459
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differential regulation and relocalization of the platelet P2Y receptors after activation: a way to avoid loss of hemostatic properties?
    Baurand A; Eckly A; Hechler B; Kauffenstein G; Galzi JL; Cazenave JP; Léon C; Gachet C
    Mol Pharmacol; 2005 Mar; 67(3):721-33. PubMed ID: 15602005
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nerve injury-activated microglia engulf myelinated axons in a P2Y12 signaling-dependent manner in the dorsal horn.
    Maeda M; Tsuda M; Tozaki-Saitoh H; Inoue K; Kiyama H
    Glia; 2010 Nov; 58(15):1838-46. PubMed ID: 20665560
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Structure of the human P2Y₁₂ receptor in complex with an antithrombotic drug.
    Du B; Liu M
    Sci China Life Sci; 2014 Jun; 57(6):645-6. PubMed ID: 24801571
    [No Abstract]   [Full Text] [Related]  

  • 66. o-Hydroxycinnamic derivatives as prospective anti-platelet candidates: in silico pharmacokinetic screening and evaluation of their binding sites on COX-1 and P2Y12 receptors.
    Nofianti KA; Ekowati J
    J Basic Clin Physiol Pharmacol; 2019 Dec; 30(6):. PubMed ID: 31855569
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of three GPCR structural templates for modeling of the P2Y12 nucleotide receptor.
    Deflorian F; Jacobson KA
    J Comput Aided Mol Des; 2011 Apr; 25(4):329-38. PubMed ID: 21461952
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Significant Discovery of Tetrahydrothieno[3,2-c]pyridine-2-carboxamide Analogs as Potent P2Y12 Receptor Antagonists.
    Bhalekar SB; Shelke SN
    Chem Biodivers; 2019 Apr; 16(4):e1800550. PubMed ID: 30629808
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibiting P2Y12 in Macrophages Induces Endoplasmic Reticulum Stress and Promotes an Anti-Tumoral Phenotype.
    Pavlović N; Kopsida M; Gerwins P; Heindryckx F
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142937
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Discovering novel inhibitors of P2Y
    Halim SA; Waqas M; Asim A; Khan M; Khan A; Al-Harrasi A
    Comput Biol Med; 2022 Aug; 147():105743. PubMed ID: 35772327
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dyspnea related to reversibly-binding P2Y12 inhibitors: A review of the pathophysiology, clinical presentation and diagnostics.
    Unverdorben M; Parodi G; Pistolesi M; Storey RF
    Int J Cardiol; 2016 Jan; 202():167-73. PubMed ID: 26386945
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interaction of Tau with G-Protein-Coupled Purinergic P2Y12 Receptor by Molecular Docking and Molecular Dynamic Simulation.
    Chidambaram H; Desale SE; Chinnathambi S
    Methods Mol Biol; 2024; 2754():33-54. PubMed ID: 38512659
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular mechanisms of platelet P2Y(12) receptor regulation.
    Cunningham MR; Nisar SP; Mundell SJ
    Biochem Soc Trans; 2013 Feb; 41(1):225-30. PubMed ID: 23356287
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lead optimization of ethyl 6-aminonicotinate acyl sulfonamides as antagonists of the P2Y12 receptor. separation of the antithrombotic effect and bleeding for candidate drug AZD1283.
    Bach P; Antonsson T; Bylund R; Björkman JA; Österlund K; Giordanetto F; van Giezen JJ; Andersen SM; Zachrisson H; Zetterberg F
    J Med Chem; 2013 Sep; 56(17):7015-24. PubMed ID: 23899349
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Modeling Membrane Protein-Ligand Binding Interactions: The Human Purinergic Platelet Receptor.
    Greene D; Botello-Smith WM; Follmer A; Xiao L; Lambros E; Luo R
    J Phys Chem B; 2016 Dec; 120(48):12293-12304. PubMed ID: 27934233
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A2
    Gdula AM; Swiatkowska M
    Microvasc Res; 2021 Nov; 138():104218. PubMed ID: 34182003
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Using ortholog sequence data to predict the functional relevance of mutations in G-protein-coupled receptors.
    Cöster M; Wittkopf D; Kreuchwig A; Kleinau G; Thor D; Krause G; Schöneberg T
    FASEB J; 2012 Aug; 26(8):3273-81. PubMed ID: 22611087
    [TBL] [Abstract][Full Text] [Related]  

  • 78. P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancer.
    Sarangi S; Pandey A; Papa AL; Sengupta P; Kopparam J; Dadwal U; Basu S; Sengupta S
    Med Oncol; 2013; 30(2):567. PubMed ID: 23568163
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Unlocking the Conformational Changes of P2Y
    Al-Najjar BO; Saqallah FG
    Molecules; 2023 May; 28(9):. PubMed ID: 37175288
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The impact of irreproducibility and competing protection from P2Y
    Cohen MV; Downey JM
    Basic Res Cardiol; 2017 Sep; 112(6):64. PubMed ID: 28952016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.